BRN

0.00%

23.0¢ brainchip holdings ltd

”BRN’s share price has been inflated, at least in part, by...

First 4 Last

Share
Profile

Follow
Stickshift

7,901 Posts.

2080

06/02/22

08:42

Post #: 59385146
Share

Originally posted by shareman: ↑

The recent events on HotCopper where BRN bulls were triggered into meltdown by a single article that raised some issues only serves to reinforce some of the views below.

As I have posted previously, for those who are brave enough to take ared pill:

- In my opinion, BRN is still a very high-risk play due to the fast-changing and ferociously competitive sector it operates in. It may well succeed (which would be great), but the chances are still reasonably low and they have their work cut out for them. If you would not bet the amount of money you have invested in BRN on a horse with a significant chance of failure, it might be wise to at least reflect on whether you may have invested more than you can afford to lose

- At this stage we just don’t know whether the Akida technology is mature and robust enough for it to be a commercial success, or whether it will end up as just a hobbyist’s toy. Only time will tell.

- There is enormous competition out there from all sorts of architectures. Despite what BRN bulls might try and convince you of, a competitor to Akida does NOT need to be another neuromorphic chip. It can be ANY architecture that satisfies the customer's needs.

- Many posters here seem to claim Akida will be placed in almost every product that exists and the only reason we have not heard about it is because it is subject to an NDA. Of course, this exact same logic could also be applied to every one of the many competitors to Akida that exist, and similarly it could be argued they have all entered into many agreements subject to an NDA too

- The reality is 99% of the times posters here have speculated that Akida might be involved in something, it will likely end up having been a competitor. The irony is the excitement generated by this speculation has helped to inflate the share price, where in reality it should actually be lowering it.

- The fact some posters here like to present BRN as having no competition, and get triggered when anyone mentions the “competitor” word, should be a big red flag

- In my view, BRN’s share price has been inflated, at least in part, by gullible and vulnerable people falling for the wild speculation posted on BrainChip Facebook groups, reddit, HC posts, telegram messages etc. In my opinion, this had resulted in significant FOMO which has manifested in the recent price action.

- The fact many BRN bulls were triggered into meltdown by a single news article that raised some issues re BRN, suggests to me:
1. posters here are far less confident in Akida than they let on;
2. contrary to what they claim, many posters here are not long term holders, as otherwise it is hard to see why they were so triggered by a single article! At the end of the day, if Akida is as good as they all claim, this article is totally irrelevant to the long term success of BRN which will be determined largely by the success of the technology itself. The fact so many posters were triggered, suggests many are in fact traders and feel the share price can only be propped up by suppressing or boycotting any view that does not support the "BRN will be worth 10x Microsoft" narrative.

Expand

”BRN’s share price has been inflated, at least in part, by gullible and vulnerable people falling for the wild speculation posted on BrainChip Facebook groups, reddit, HC posts, telegram messages etc”

100%

BRN Price at posting: $1.74 Sentiment: None Disclosure: Not Held
13 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 156 more messages in this thread...

First 4 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $451.3M

Open	High	Low	Value	Volume
23.0¢	24.0¢	21.5¢	$2.863M	12.69M

Buyers (Bids)

No.	Vol.	Price($)
6	136498	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	444756	13

View Market Depth

No.	Vol.	Price($)
4	86498	0.230
3	155000	0.225
16	439886	0.220
14	751341	0.215
35	871743	0.210

Price($)	Vol.	No.
0.235	360988	11
0.240	791244	17
0.245	612347	15
0.250	151787	5
0.255	132485	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

BRN (ASX) Chart

”BRN’s share price has been inflated, at least in part, by...

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

”BRN’s share price has been inflated, at least in part, by...

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News